S
SEGNOS
Japan · Healthtech
SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.
Product
The Chiba-based company develops and manufactures Therma-Max, a temperature-responsive magnetic nanoparticle material. It is working on methods to detect small quantities of disease-related markers in blood.
Founded through a carve-out from JNC in 2024, SEGNOS combines its material technology with diagnostic-assay research. Founder Noriyuki Onishi leads the company, which is developing materials and test kits for healthcare applications.
Funding history
1 round · 0 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-Series A | Undisclosed | TUAT1号投資事業有限責任組合 — Participant |